Agents/press release/2026-10-15

Google DeepMind's Antigravity workflow aids drug discovery and identifies antimicrobial peptide candidate

Google DeepMind announced its Antigravity, an agentic cheminformatics workflow designed to accelerate drug discovery. The company claims this workflow has successfully identified a potential antimicrobial peptide candidate. The central claims regarding Antigravity's capabilities and findings are primarily reported by Google DeepMind itself.

3 articles from 3 outlets covered this story. The underlying claim is sourced from a press release.

What do all outlets agree on?

3 outlets covered “Google DeepMind's Antigravity workflow aids drug discovery and identifies antimicrobial…”. All of them report the following:

  • Google DeepMind developed Antigravity
  • Antigravity is an agentic cheminformatics workflow
  • It aims to enhance drug discovery
  • It identified an antimicrobial peptide candidate

Which outlets covered this?

All 3 articles found on this story, grouped by the stance of the piece. Every link goes to the original publisher.

What related stories are there?

Which companies does this involve?

Get the week in AI in one email

What happened, which outlets reported it, and where their coverage differed. One issue a week.

The first issue hasn’t gone out yet. Subscribe and it’s the one you’ll get.

We’ll send the digest and nothing else. One-click unsubscribe. Privacy.